LAURA H. CYPHERS

This Medical News article discusses telehealth payment issues that extend beyond the COVID-19 public health emergency, which is set to expire in mid-July.
Source: JAMA Online First

This JAMA Patient Page describes 2 new oral antiviral medications that are available for patients with mild to moderate COVID-19 who are not hospitalized but are at high risk of developing severe disease.
Source: JAMA Online First

In the Original Investigation titled “Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment: The SYSUCC-001 Randomized Clinical Trial,” published in the January 5, 2021, issue of JAMA, the labels for some of the y-axes and panels were incorrect. Figure 2A, C, and D should have included disease recurrence or death (instead of just mortality) in the labels for the panels and y-axes. This article has been corrected online.
Source: JAMA Online First

In this Viewpoint, Joynt Maddox and colleagues consider how the bundled payment programs from the Centers for Medicare & Medicaid Services require close examination of benchmarks, market distortions, and health equity.
Source: JAMA Online First

This study uses data from the Vaccine Safety Datalink on receipt of booster doses of COVID-19 vaccines among pregnant individuals aged 18 to 49 years.
Source: JAMA Online First

This Viewpoint discusses efforts by the Centers for Medicare & Medicaid Services to improve operations as well as implement policies that advance health equity.
Source: JAMA Online First

This JAMA Insights in the Women’s Health series describes the identification and management of dyspareunia to help address sexual pain; successful treatment can have benefits for both physical and mental health.
Source: JAMA Online First

This Viewpoint discusses key tenets of developing diagnostic acumen, including gathering and integrating data, applying iterative bayesian thinking, choosing the format of communication, and determining the urgency of diagnosis.
Source: JAMA Online First

This Viewpoint documents the history, value, and success of the 340B Pricing Program, which is under threat from pharmaceutical corporations’ withdrawal and from a pending Supreme Court decision and offers 2 legislative fixes to address the concerns raised by the pharmaceutical companies.
Source: JAMA Online First

This Viewpoint discusses the ways in which the updated Standards for Continuing Certification reflect foundational changes in how the American Board of Medical Specialties and the member boards perform professional self-regulation, including the intent of the Standards to bring value to both the public and the profession.
Source: JAMA Online First